- Home
- SSTK vs MGTX Comparison
SSTK vs MGTX Comparison
Compare SSTK & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTK
- MGTX
- Stock Information
- Founded
- SSTK 2003
- MGTX 2015
- Country
- SSTK United States
- MGTX United States
- Employees
- SSTK N/A
- MGTX N/A
- Industry
- SSTK EDP Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSTK Technology
- MGTX Health Care
- Exchange
- SSTK Nasdaq
- MGTX Nasdaq
- Market Cap
- SSTK 668.4M
- MGTX 670.2M
- IPO Year
- SSTK 2012
- MGTX N/A
- Fundamental
- Price
- SSTK $21.91
- MGTX $7.83
- Analyst Decision
- SSTK Buy
- MGTX Strong Buy
- Analyst Count
- SSTK 4
- MGTX 2
- Target Price
- SSTK $43.67
- MGTX $24.00
- AVG Volume (30 Days)
- SSTK 271.5K
- MGTX 522.1K
- Earning Date
- SSTK 07-29-2025
- MGTX 08-14-2025
- Dividend Yield
- SSTK 6.00%
- MGTX N/A
- EPS Growth
- SSTK 38.48
- MGTX N/A
- EPS
- SSTK 1.81
- MGTX N/A
- Revenue
- SSTK $1,010,504,000.00
- MGTX $37,917,000.00
- Revenue This Year
- SSTK $10.45
- MGTX $145.67
- Revenue Next Year
- SSTK $3.19
- MGTX $167.61
- P/E Ratio
- SSTK $12.13
- MGTX N/A
- Revenue Growth
- SSTK 14.20
- MGTX 366.84
- 52 Week Low
- SSTK $14.35
- MGTX $3.85
- 52 Week High
- SSTK $38.80
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- SSTK 60.81
- MGTX 49.11
- Support Level
- SSTK $20.92
- MGTX $7.43
- Resistance Level
- SSTK $22.45
- MGTX $8.63
- Average True Range (ATR)
- SSTK 0.96
- MGTX 0.45
- MACD
- SSTK 0.08
- MGTX -0.06
- Stochastic Oscillator
- SSTK 82.12
- MGTX 40.89
About SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.